These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 241025)

  • 1. Effect of bulbocapnine as a peripheral dopamine receptor antagonists in the anesthetized cat.
    Pendleton RG; Finlay E; Sherman S
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(2):171-8. PubMed ID: 241025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of responses to dopamine in the mesenteric vascular bed of the cat.
    Lippton HL; Meyer RL; Parey SE; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):136-49. PubMed ID: 6114715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal vasodilation by a prostaglandin analog during dopaminergic and alpha-adrenergic blockade.
    Seymour AA; Blaine EH
    Prostaglandins Leukot Med; 1983 Mar; 10(3):349-60. PubMed ID: 6133286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
    Setler PE; Pendleton RG; Finlay E
    J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bulbocapnine is not a selective DA1 receptor antagonist.
    Kohli JD; Glock D; Goldberg LI
    J Pharm Pharmacol; 1986 May; 38(5):401-2. PubMed ID: 2872323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dopamine and blockade of dopaminergic and adrenergic receptors on coronary blood flow in ischemic rabbit myocardium.
    Rosolowsky M; Weiss HR
    J Cardiovasc Pharmacol; 1985; 7(4):700-8. PubMed ID: 2410711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the effects of apomorphine and bulbocapnine in relation to the proposed dopamine receptor.
    Patil PN; Burkman AM; Yamauchi D; Hetey S
    J Pharm Pharmacol; 1973 Mar; 25(3):221-8. PubMed ID: 4146322
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonism by bulbocapnine of adrenergic inhibition in parasympathetic ganglia in the urinary bladder.
    Saum WR; Groat WC
    Brain Res; 1972 Feb; 37(2):340-4. PubMed ID: 4400795
    [No Abstract]   [Full Text] [Related]  

  • 9. The depressor and renal vasodilator responses to dopamine in the rat do not depend on prostaglandin biosynthesis.
    Robertson MJ; Horn NM; Chapman BJ
    J Pharm Pharmacol; 1980 Nov; 32(11):782-5. PubMed ID: 6110729
    [No Abstract]   [Full Text] [Related]  

  • 10. A dopamine receptor in esophageal smooth muscle of the opossum.
    de Carle DJ; Christensen J
    Gastroenterology; 1976 Feb; 70(2):216-9. PubMed ID: 2511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dopamine on the conductance of perfused vascular beds of the chloralosed cat.
    Hamilton TC
    Br J Pharmacol; 1972 Mar; 44(3):442-50. PubMed ID: 4402742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies concerning dopamine diuresis in the rat.
    Pendleton RG; Sherman SS
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):94-102. PubMed ID: 10862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possibe mechanisms involved in the depressor response to dopamine.
    Morishita H; Furukawa T
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):317-27. PubMed ID: 4447412
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels.
    Edvinsson L; Hardebo JE; McCulloch J; Owman C
    Acta Physiol Scand; 1978 Nov; 104(3):349-59. PubMed ID: 716985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the depressor response to dopamine in the rat treated with phenoxybenzamine.
    Chevillard C; Mathieu MN
    Eur J Pharmacol; 1979 Jul; 56(4):371-8. PubMed ID: 477731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propranolol on the blockade of alpha adrenergic receptors.
    Yamamura HI; Horita A
    J Pharmacol Exp Ther; 1968 Nov; 164(1):82-9. PubMed ID: 5722108
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood flow redistribution by dopamine in the feline gastrointestinal tract.
    Kullmann R; Breull WR; Wassermann K; Konopatzki A
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):145-8. PubMed ID: 6136919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasomotor response of cerebral blood vessels to dopamine and dopaminergic agonists.
    Edvinsson L; Hardebo JE; McCulloch J; Owman C
    Adv Neurol; 1978; 20():85-96. PubMed ID: 676925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of vascular dopamine receptors in the gastric circulation of the rabbit.
    Reinsberg J; Kullmann R
    J Cardiovasc Pharmacol; 1986; 8(5):1067-73. PubMed ID: 2429081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bulbocapnine's ability to antagonize the adrenergic inhibitory action of dopamine and analogs.
    Ilhan M; Long JP; Cannon JG
    Eur J Pharmacol; 1975 Aug; 33(1):13-8. PubMed ID: 240727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.